AFT Pharmaceuticals Limited
AFT Pharmaceuticals Limited
- P/E ratio
- 32.46
Your view on AFP.AX
Overview
What the company does, where it operates, and who runs it.
About AFT Pharmaceuticals Limited
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- CEO
- Hartley Atkinson
- Headquarters
- 129 Hurstmere Road, Auckland, AUK, NZ
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- CEO
- Hartley Atkinson
- Headquarters
- 129 Hurstmere Road, Auckland, AUK, NZ
AFT Pharmaceuticals Limited engages in the complete lifecycle of pharmaceutical products, from their initial development and licensing to their distribution and ultimate sale. The company's reach extends throughout New Zealand, Australia, Asia, and various other international markets.
Its extensive product range encompasses treatments for allergies, cold and flu symptoms, ophthalmic conditions, first aid, pain management, digestive health, dermatological concerns, and medicated vitamin supplements. Established in 1997, AFT Pharmaceuticals has its corporate headquarters situated in Auckland, New Zealand.
Stock Data
Price chart, volume, and trading data.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for AFT Pharmaceuticals Limited. Starting points for AFT Pharmaceuticals Limited: P/E 32.5, EPS AUD 0.14, beta 0.42 — an Drug Manufacturers - Specialty & Generic name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
About this section
Dividend history, yield and payout sustainability for AFT Pharmaceuticals Limited. AFT Pharmaceuticals Limited does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for AFT Pharmaceuticals Limited. Trailing twelve-month EPS for AFT Pharmaceuticals Limited stands at AUD 0.14. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Wall Street Analyst Estimates
Analysts' price targets, ratings, and revenue and EPS estimates.
Earnings per share estimates
| Per share | This quarterSep 2026 | Next quarterMar 2027 | This yearYear to Mar 2027 | Next yearYear to Mar 2028 |
|---|---|---|---|---|
| Average estimate | NZD 0.00 | NZD 0.00 | NZD 0.19 | NZD 0.24 |
| Lowest estimate | NZD 0.00 | NZD 0.00 | NZD 0.19 | NZD 0.23 |
| Highest estimate | NZD 0.00 | NZD 0.00 | NZD 0.19 | NZD 0.24 |
| Number of analysts | 0 | 0 | 1 | 1 |
| A year ago | NZD 0.061 | NZD 0.081 | NZD 0.15 | — |
| Growth vs a year ago | — | — | +24.9% | — |
1The year-ago figure includes one-time items, so growth is not shown.
Revenue estimates
| Total | This quarterSep 2026 | Next quarterMar 2027 | This yearYear to Mar 2027 | Next yearYear to Mar 2028 |
|---|---|---|---|---|
| Average estimate | NZD 138.03M | NZD 170.41M | NZD 309.67M | NZD 351.87M |
| Lowest estimate | NZD 138.03M | NZD 170.41M | NZD 308.82M | NZD 349.24M |
| Highest estimate | NZD 138.03M | NZD 170.41M | NZD 310.53M | NZD 354.49M |
| Number of analysts | 1 | 1 | 2 | 2 |
| A year ago | NZD 64.28M | NZD 90.89M | NZD 256.56M | — |
| Growth vs a year ago | +114.7% | +87.5% | +20.7% | — |
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for AFT Pharmaceuticals Limited. AFT Pharmaceuticals Limited has reported as a listed company since 2016. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
| Ticker | Type | Company | Sector | Industry | |
|---|---|---|---|---|---|
| ARX.AXAroa Biosurgery Limited | Healthcare | Medical - Devices | — | ||
| AVR.AXAnteris Technologies Ltd | Healthcare | Medical - Devices | — | ||
| BOT.AXBotanix Pharmaceuticals Limited | Healthcare | Biotechnology | — | ||
| DXB.AXDimerix Limited | Healthcare | Biotechnology | — | ||
| IMR.AXImricor Medical Systems, Inc. | Healthcare | Medical - Specialties | — | ||
| MVF.AXMonash IVF Group Limited | Healthcare | Medical - Diagnostics & Research | — | ||
| MYX.AXMayne Pharma Group Limited | Healthcare | Medical - Pharmaceuticals | — | ||
| OCC.AXOrthocell Limited | Healthcare | Biotechnology | — | ||
| Ticker | Type | Company | Sector | Exchange | Mkt cap |
|---|---|---|---|---|---|
| TRUFFRed Light Holland Corp. | Healthcare | OTC | $5.5M | ||
| TSMRFTsumura & Co. | Healthcare | OTC | $1.7B | ||
| PAHCPhibro Animal Health Corporation | Healthcare | NASDAQ | $1.4B | ||
| PAIOFPaion AG | Healthcare | OTC | $75,264 | ||
| PBF.CNPlanet Based Foods Global Inc. | Healthcare | CNQ | $1.4M | ||
| PBFFFPlanet Based Foods Global Inc. | Healthcare | OTC | $825,651 | ||
| PCLO.VPharmaCielo Ltd. | Healthcare | TSXV | — | ||
| PCLOFPharmaCielo Ltd. | Healthcare | OTC | $7.1M | ||
| PCRXPacira BioSciences, Inc. | Healthcare | NASDAQ | $1.5B | ||
| PCYNProcyon Corporation | Healthcare | OTC | $1.5M | ||
| PEMTFThoughtful Brands Inc. | Healthcare | OTC | $368 | ||
| PER.AXPercheron Therapeutics Limited | Healthcare | ASX | — | ||

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of AFT Pharmaceuticals Limited.